Doxorubicin and vinorelbine act independently via p53 expression and p38 activation respectively in breast cancer cell lines

In the treatment of breast cancer, combination chemotherapy is used to overcome drug resistance. Combining doxorubicin and vinorelbine in the treatment of patients with metastatic breast cancer has shown high response rates; even single-agent vinorelbine in patients previously exposed to anthracycli...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Liem, A A, Appleyard, M V C L, O'Neill, M A, Hupp, T R, Chamberlain, M P, Thompson, A M
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2003
Assuntos:
Experimental Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2747573/
https://ncbi.nlm.nih.gov/pubmed/12698197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600898
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares